Clorox (NYSE:CLX)‘s stock had its “neutral” rating restated by JPMorgan Chase & Co. in a research report issued on Tuesday. They presently have a $138.00 price target on the stock, down from their previous price target of $139.00. JPMorgan Chase & Co.’s price objective suggests a potential upside of 5.28% from the stock’s previous close.
Several other equities analysts have also issued reports on the company. Deutsche Bank assumed coverage on Clorox in a research note on Wednesday, December 13th. They issued a “hold” rating and a $142.00 target price on the stock. Wells Fargo & Co restated a “hold” rating and set a $130.00 price target on shares of Clorox in a research note on Wednesday, December 13th. Jefferies Group restated a “hold” rating and set a $130.00 price target on shares of Clorox in a research note on Wednesday, December 13th. Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and set a $155.00 price target on the stock in a research note on Thursday, January 4th. Finally, Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $163.00 price target on the stock in a research note on Monday, January 8th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $132.61.
Shares of Clorox (CLX) traded down $0.11 during trading on Tuesday, hitting $131.08. The stock had a trading volume of 53,107 shares, compared to its average volume of 1,111,175. The stock has a market capitalization of $16,870.40, a price-to-earnings ratio of 21.65, a P/E/G ratio of 2.44 and a beta of 0.39. The company has a debt-to-equity ratio of 2.35, a quick ratio of 0.86 and a current ratio of 1.22. Clorox has a 1 year low of $124.09 and a 1 year high of $150.40.
Several institutional investors have recently added to or reduced their stakes in CLX. Victory Capital Management Inc. lifted its holdings in Clorox by 18.5% in the third quarter. Victory Capital Management Inc. now owns 23,010 shares of the company’s stock valued at $3,035,000 after acquiring an additional 3,596 shares during the period. Dupont Capital Management Corp acquired a new position in Clorox in the third quarter valued at approximately $199,000. State of Wisconsin Investment Board lifted its holdings in Clorox by 490.9% in the third quarter. State of Wisconsin Investment Board now owns 51,513 shares of the company’s stock valued at $6,795,000 after acquiring an additional 42,796 shares during the period. Candriam Luxembourg S.C.A. lifted its holdings in Clorox by 4.0% in the third quarter. Candriam Luxembourg S.C.A. now owns 10,599 shares of the company’s stock valued at $1,398,000 after acquiring an additional 403 shares during the period. Finally, Jennison Associates LLC lifted its holdings in Clorox by 1.5% in the third quarter. Jennison Associates LLC now owns 311,251 shares of the company’s stock valued at $41,057,000 after acquiring an additional 4,551 shares during the period. 75.77% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Clorox (CLX) Given Neutral Rating at JPMorgan Chase & Co.” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.americanbankingnews.com/2018/03/13/clorox-clx-price-target-cut-to-138-00-by-analysts-at-jpmorgan-chase-co.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.